90 related articles for article (PubMed ID: 11996001)
41. Structural analysis of Pneumocystis carinii dihydrofolate reductase complexed with NADPH and 2,4-diamino-6-[2-(5-carboxypent-1-yn-1-yl)-5-methoxybenzyl]-5-methylpyrido[2,3-d]pyrimidine.
Cody V; Pace J; Stewart E
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Apr; 68(Pt 4):418-23. PubMed ID: 22505410
[TBL] [Abstract][Full Text] [Related]
42. Thermodynamics and solvent effects on substrate and cofactor binding in Escherichia coli chromosomal dihydrofolate reductase.
Grubbs J; Rahmanian S; DeLuca A; Padmashali C; Jackson M; Duff MR; Howell EE
Biochemistry; 2011 May; 50(18):3673-85. PubMed ID: 21462996
[TBL] [Abstract][Full Text] [Related]
43. Engineering specificity for folate into dihydrofolate reductase from Escherichia coli.
Posner BA; Li L; Bethell R; Tsuji T; Benkovic SJ
Biochemistry; 1996 Feb; 35(5):1653-63. PubMed ID: 8634297
[TBL] [Abstract][Full Text] [Related]
44. Dihydrofolate reductase from the pathogenic fungus Pneumocystis carinii: catalytic properties and interaction with antifolates.
Margosiak SA; Appleman JR; Santi DV; Blakley RL
Arch Biochem Biophys; 1993 Sep; 305(2):499-508. PubMed ID: 8373187
[TBL] [Abstract][Full Text] [Related]
45. Further studies on the role of water in R67 dihydrofolate reductase.
Timson MJ; Duff MR; Dickey G; Saxton AM; Reyes-De-Corcuera JI; Howell EE
Biochemistry; 2013 Mar; 52(12):2118-27. PubMed ID: 23458706
[TBL] [Abstract][Full Text] [Related]
46. Selective probing of a NADPH site controlled light-induced enzymatic catalysis.
Lambry JC; Beaumont E; Tarus B; Blanchard-Desce M; Slama-Schwok A
J Mol Recognit; 2010; 23(4):379-88. PubMed ID: 20029835
[TBL] [Abstract][Full Text] [Related]
47. Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.
Cody V; Luft JR; Pangborn W; Gangjee A; Queener SF
Acta Crystallogr D Biol Crystallogr; 2004 Apr; 60(Pt 4):646-55. PubMed ID: 15039552
[TBL] [Abstract][Full Text] [Related]
48. Structural studies on bio-active compounds. 20. Molecular modeling and crystallographic studies on methylbenzoprim, a potent inhibitor of dihydrofolate reductase.
Denny BJ; Ringan NS; Schwalbe CH; Lambert PA; Meek MA; Griffin RJ; Stevens MF
J Med Chem; 1992 Jun; 35(12):2315-20. PubMed ID: 1613754
[TBL] [Abstract][Full Text] [Related]
49. The electrostatic potential of Escherichia coli dihydrofolate reductase.
Bajorath J; Kitson DH; Kraut J; Hagler AT
Proteins; 1991; 11(1):1-12. PubMed ID: 1961697
[TBL] [Abstract][Full Text] [Related]
50. Exploring PfDHFR reaction surface: A combined molecular dynamics and QM/MM analysis.
Abbat S; Jaladanki CK; Bharatam PV
J Mol Graph Model; 2019 Mar; 87():76-88. PubMed ID: 30508692
[TBL] [Abstract][Full Text] [Related]
51. Exploring the molecular mechanism of dihydrofolate reductase.
Brown KA; Kraut J
Faraday Discuss; 1992; (93):217-24. PubMed ID: 1290933
[TBL] [Abstract][Full Text] [Related]
52. Sequential conformation changes of chinese hamster ovary dihydrofolate reductase at its active sites.
Zhang WH; Qin SB; Zhang HJ; Zhu ZY
Protein Pept Lett; 2005 Jul; 12(5):483-6. PubMed ID: 16029162
[TBL] [Abstract][Full Text] [Related]
53. QSAR studies on biological activity of piritrexim analogues against pc DHFR.
Agrawal VK; Sohgaura R; Khadikar PV
Bioorg Med Chem; 2002 Sep; 10(9):2919-26. PubMed ID: 12110313
[TBL] [Abstract][Full Text] [Related]
54. Computational algorithmic and molecular dynamics study of functional and structural impacts of non-synonymous single nucleotide polymorphisms in human DHFR gene.
Alam MS; Saleh MA; Mozibullah M; Riham AT; Solayman M; Gan SH
Comput Biol Chem; 2021 Dec; 95():107587. PubMed ID: 34710812
[TBL] [Abstract][Full Text] [Related]
55. Osmolyte induced enhancement of expression and solubility of human dihydrofolate reductase: An in vivo study.
Rashid N; Thapliyal C; Chaudhuri Chattopadhyay P
Int J Biol Macromol; 2017 Oct; 103():1044-1053. PubMed ID: 28551440
[TBL] [Abstract][Full Text] [Related]
56. Engineering and Modeling the Electrophoretic Trapping of a Single Protein Inside a Nanopore.
Willems K; Ruić D; Biesemans A; Galenkamp NS; Van Dorpe P; Maglia G
ACS Nano; 2019 Sep; 13(9):9980-9992. PubMed ID: 31403770
[TBL] [Abstract][Full Text] [Related]
57. Synergistic Enhancement of Enzyme Performance and Resilience via Orthogonal Peptide-Protein Chemistry Enabled Multilayer Construction.
Zhang XJ; Wang XW; Sun JX; Su C; Yang S; Zhang WB
Biomacromolecules; 2018 Jul; 19(7):2700-2707. PubMed ID: 29768002
[TBL] [Abstract][Full Text] [Related]
58. Structural and Dynamics Perspectives on the Binding of Substrate and Inhibitors in Mycobacterium tuberculosis DHFR.
Sittikornpaiboon P; Toochinda P; Lawtrakul L
Sci Pharm; 2017 Sep; 85(3):. PubMed ID: 28914808
[TBL] [Abstract][Full Text] [Related]
59. Electronic properties investigation of human dihydrofolate reductase complexes with ligands.
Naumovich V; Grishina M; Novak J; Pathak P; Potemkin V; Shahbaaz M; Abdellattif MH
J Biomol Struct Dyn; 2022 Jul; 40(11):4775-4790. PubMed ID: 33345753
[TBL] [Abstract][Full Text] [Related]
60. A new approach to the automatic identification of candidates for ligand receptor sites in proteins: (I). Search for pocket regions.
Del Carpio CA; Takahashi Y; Sasaki S
J Mol Graph; 1993 Mar; 11(1):23-9, 42. PubMed ID: 8499393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
